{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:29:39Z","timestamp":1790357379980,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ccm.2011.02.015","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T10:42:05Z","timestamp":1303468925000},"page":"399-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Alternatives to Lung Transplantation: Treatment of Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"32","author":[{"given":"Paul A.","family":"Corris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2011.02.015_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2008.07.018","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart\/lung transplantation report\u20132008","volume":"27","author":"Christie","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2011.02.015_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.161.2.9906015","article-title":"Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing","volume":"161","author":"Miyamoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.0000022687.18568.2A","article-title":"Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing","volume":"106","author":"Wensel","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0002-9149(98)00140-4","article-title":"Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension","volume":"81","author":"Yeo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","article-title":"Tricuspid annular displacement predicts survival in pulmonary hypertension","volume":"174","author":"Forfia","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.0000084544.54513.E2","article-title":"Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension","volume":"108","author":"Torbicki","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib12","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/eurheartj\/ehi728","article-title":"Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension","volume":"27","author":"Provencher","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccm.2011.02.015_bib14","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1161\/01.CIR.96.9.2782","article-title":"Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension","volume":"96","author":"Friedman","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mvr.2004.06.001","article-title":"Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension","volume":"68","author":"Mandegar","year":"2004","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ccm.2011.02.015_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(84)91452-1","article-title":"Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)","volume":"1","author":"Higenbottam","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2011.02.015_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1378\/chest.114.5.1269","article-title":"A\u00a0survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension","volume":"114","author":"Robbins","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib21","first-page":"679","article-title":"The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation","volume":"17","author":"Conte","year":"1998","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2011.02.015_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/hrt.80.2.151","article-title":"Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension","volume":"80","author":"Higenbottam","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.ccm.2011.02.015_bib25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.ccm.2011.02.015_bib26","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib27","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0735-1097(99)00320-4","article-title":"The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension","volume":"34","author":"Rich","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib29","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1378\/chest.121.5.1561","article-title":"Transitioning from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension","volume":"121","author":"Vachiery","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","article-title":"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension","volume":"172","author":"Gomberg-Maitland","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0b013e31802b3184","article-title":"Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension","volume":"49","author":"Sitbon","year":"2007","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.ccm.2011.02.015_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib33","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.01.17100140","article-title":"Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension","volume":"17","author":"Gessler","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2011.02.015_bib36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2011.02.015_bib38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib39","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2011.02.015_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ccm.2011.02.015_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1164\/rccm.200307-957OC","article-title":"Sitaxsentan therapy for pulmonary arterial hypertension","volume":"169","author":"Barst","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"47","key":"10.1016\/j.ccm.2011.02.015_bib43","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","article-title":"Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan","volume":"16","author":"Barst","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib44","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib45","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib46","doi-asserted-by":"crossref","first-page":"s39003","DOI":"10.1378\/chest.134.4_MeetingAbstracts.s39003","article-title":"Tadalafil improves exercise capacity, health-related quality of life and delays time to clinical worsening in patients with symptomatic pulmonary arterial hypertension","volume":"134","author":"Barst","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ahj.2007.02.037","article-title":"A\u00a0meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology","volume":"153","author":"Macchia","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccm.2011.02.015_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A\u00a0meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccm.2011.02.015_bib49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1378\/chest.06-2913","article-title":"Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension","volume":"132","author":"Jing","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effects of high doses of calcium channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib51","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1378\/chest.129.6.1636","article-title":"Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension","volume":"129","author":"Lang","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib52","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehi283","article-title":"Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension","volume":"26","author":"Opitz","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccm.2011.02.015_bib53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1183\/09031936.00130408","article-title":"Long-term outcome with intravenous iloprost in pulmonary arterial hypertension","volume":"34","author":"Hoeper","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2011.02.015_bib54","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/ard.2005.048967","article-title":"Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions","volume":"65","author":"Denton","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ccm.2011.02.015_bib55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09031936.05.00054804","article-title":"Survival with first-line bosentan in patients with primary pulmonary hypertension","volume":"25","author":"McLaughlin","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2011.02.015_bib56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.healun.2006.11.009","article-title":"Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan","volume":"26","author":"Keogh","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2011.02.015_bib57","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/hrt.2005.069484","article-title":"Systemic sclerosis associated pulmonary hypertension: improved survival in the current era","volume":"92","author":"Williams","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ccm.2011.02.015_bib58","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/eurheartj\/ehl017","article-title":"Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome","volume":"27","author":"Adriaenssens","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccm.2011.02.015_bib59","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.healun.2007.07.012","article-title":"Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment","volume":"26","author":"Dandel","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2011.02.015_bib60","series-title":"A\u00a036-month survival analysis of patients beginning oral PAH monotherapy: an indication for escalation of therapy?","author":"Tankersley","year":"2008"},{"key":"10.1016\/j.ccm.2011.02.015_bib61","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1378\/chest.91.5.675","article-title":"Primary pulmonary hypertension. Length of survival in patients referred for heart\u2013lung transplantation","volume":"91","author":"Glanville","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib62","first-page":"100","article-title":"Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome","volume":"15","author":"Hopkins","year":"1996","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2011.02.015_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(98)00238-1","article-title":"Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment","volume":"32","author":"Sandoval","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib64","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/01.CIR.91.7.2028","article-title":"Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension","volume":"91","author":"Kerstein","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib65","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1378\/chest.06-1227","article-title":"Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension","volume":"131","author":"Kurzyna","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib66","first-page":"173","article-title":"A\u00a0modified technique of stent fenestration of the interatrial septum improves patients with pulmonary hypertension","volume":"73","author":"Troost","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ccm.2011.02.015_bib67","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9149(99)00416-6","article-title":"Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension","volume":"84","author":"Rothman","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib68","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib69","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology","volume":"25","author":"Galie","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccm.2011.02.015_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1540-8191.1989.tb00253.x","article-title":"Technique of pulmonary thromboendarterectomy for chronic pulmonary embolism","volume":"4","author":"Daily","year":"1989","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.ccm.2011.02.015_bib71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-5223(19)33748-1","article-title":"Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period","volume":"106","author":"Jamieson","year":"1993","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2011.02.015_bib72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1010-7940(99)00116-5","article-title":"Angioscopic video-assisted pulmonary endarterectomy for postembolic pulmonary hypertension","volume":"16","author":"Dartevelle","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ccm.2011.02.015_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejcts.2007.11.009","article-title":"Pulmonary endarterectomy is possible and effective without the use of complete circulatory arrest\u2014the UK experience in over 150 patients","volume":"33","author":"Thomson","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ccm.2011.02.015_bib74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.CIR.0000111841.28126.D4","article-title":"Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension","volume":"109","author":"Kim","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2011.02.015_bib75","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1538-7836.2007.02394.x","article-title":"Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension","volume":"5","author":"Skoro-Sajer","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ccm.2011.02.015_bib76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.81.2.151","article-title":"Long-term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data","volume":"81","author":"Riedel","year":"1982","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib77","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1378\/chest.119.3.818","article-title":"Prognostic factors in medically treated patients with chronic pulmonary embolism","volume":"119","author":"Lewczuk","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib78","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/ajrccm.160.2.9808109","article-title":"Long-term outcome after pulmonary thromboendarterectomy","volume":"160","author":"Archibald","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2011.02.015_bib79","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1183\/09031936.04.00020004","article-title":"Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension","volume":"23","author":"Bresser","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2011.02.015_bib80","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","article-title":"Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial","volume":"52","author":"Jais","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2011.02.015_bib81","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1378\/chest.07-2681","article-title":"Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension","volume":"134","author":"Suntharalingam","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2011.02.015_bib82","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1183\/09031936.00039007","article-title":"Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension","volume":"30","author":"Reichenberger","year":"2007","journal-title":"Eur Respir J"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523111000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523111000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:46:05Z","timestamp":1759452365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523111000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0272523111000293"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2011.02.015","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternatives to Lung Transplantation: Treatment of Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2011.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}